Click here to load reader
Upload
tga-australia
View
400
Download
0
Embed Size (px)
Citation preview
Advertising cosmetic injectables Complying with the therapeutic goods legislation
Virginia Deigan Assistant Director, Advertising & Recalls Section, Office of Product Review, TGA Sydney International Spa & Beauty Expo 23-24 August 2014
Therapeutic Goods Administration The TGA was established in 1990 to ‘safeguard and enhance the health of the Australian community through effective and timely regulation of therapeutic goods’.
Advertising cosmetic injectables 1
TGA’s role • Regulates the manufacture, import, export, supply and advertising of therapeutic goods such as prescription,
over-the-counter and complementary medicines, medical devices (including in-vitro diagnostic devices (IVDs), biologicals, blood and blood products.
• This is done through – pre-market assessment and labelling
– post-market monitoring and enforcement of standards, including advertising requirements
– licensing of Australian manufacturers and verifying overseas manufacturers' compliance with the same standards as their Australian counterparts
Advertising cosmetic injectables 2
What the TGA doesn’t do • Recommendations/decisions about which devices/medicines receive Government subsidy; • Give clinical advice regarding treatment of patients; • Regulate practices or services of healthcare professionals; • Fund research on the development of therapeutic goods.
Advertising cosmetic injectables 3
National medicines policy • One of the central objectives of Australia’s National Medicines Policy is:
– quality use of medicines (QUM);
Advertising cosmetic injectables 4
Quality Use of Medicines (QUM) • QUM means:
– selecting management options wisely; – choosing suitable medicines, if a medicine is considered necessary; and – using those medicines safely and effectively.
Advertising cosmetic injectables 5
Scheduling • Medicines and chemicals are classified into Schedules according to the level of regulatory control over their
availability, required to protect public health and safety. The schedules are published in the Poisons Standard: • There are 9 Schedules, but the schedule most relevant to cosmetic injectables is:
– Schedule 4 – Prescription Only Medicine
6 Advertising cosmetic injectables
Scheduling of cosmetic injectables • The most common scheduled substances used in non-surgical cosmetic procedures are:
– Botulinum Toxin = Schedule 4 – Hylauronic Acid = Schedule 4 – Hylauronic Acid = Schedule 4
7 Advertising cosmetic injectables
What is an advertisement? • The definition of “advertisement” under the Act is very broad:
– ‘...in relation to therapeutic goods, includes any statement, pictorial representation or design, however made, that is intended, whether directly or indirectly, to promote the use or supply of the goods’
8 Advertising cosmetic injectables
Can Schedule 4 substances be advertised to the public? • Section 42DL(1)(f) of the Therapeutic Goods Act 1989 is an offence provision:
– A person must not publish or broadcast an advertisement about therapeutic goods that contains a statement referring to goods, or substances or preparations containing goods, included in Schedule 3, 4 or 8 to the current Poisons Standard, other than a statement authorised or required by a government or government authority (including a foreign government or foreign government authority);
9 Advertising cosmetic injectables
What is the effect of s42DL(1)(f)? • Schedule 4 substances used in cosmetic medical procedures such as anti-wrinkle treatments, are captured
under this section of the Act, if advertised to the general public.
10 Advertising cosmetic injectables
Is my website an advertisement for a therapeutic good? • Generally, any website that is promotional in some way and also refers to a therapeutic good, is likely to be
taken to be an advertisement for a therapeutic good. • Whether or not the advertisement is intended to promote the use or supply of a therapeutic good, comes
down to whatever the customer believes the intention of the information is, or put it another way, what the impact on the customer is.
11 Advertising cosmetic injectables
How to comply with s42DL(1)(f) • Advertisements to consumers for cosmetic services must not specify:
– trade names of products containing Schedule 4 substances (e.g. Botox, Dysport, Restylane, Perlane, Dermalive, Juvéderm, Aquamid, Sculptra)
– ingredients that are Schedule 4 substances (e.g. botulinum toxin, hyaluronic acid, polylactic acid) – acronyms, abbreviations or other references to such trade names and ingredient names (e.g. BTX, HA,
colloquial terms for specific products/substances).
12 Advertising cosmetic injectables
Social media A common area of non-compliance is third-party posts on Facebook, websites etc. • The owner of the website/Facebook page is responsible for the content, this includes any
third-part posts, for example, testimonials or messages left by your clients. • Any posts that may cause the material to be non-compliant with the therapeutic goods advertising legislation
should be removed as soon as you become aware of it. • It is recommended for businesses to have a process in place for regular monitoring.
13 Advertising cosmetic injectables
Consequences of non-compliance • In the first instance, the TGA seeks to inform, educate and assist advertisers to comply with the rules relating
to advertising. • If this approach fails, the TGA may take regulatory action. The Act provides for financial penalties for a breach
of 42DL(1)(f). Penalties can be: – Up to $10,200 for individuals; and – Up to $51,000 for corporations
14 Advertising cosmetic injectables
Educational material • There are a number of resources available to assist advertisers
to comply with the therapeutic goods advertising legislation: – Brochure – Website information - www.tga.gov.au
15 Advertising cosmetic injectables